Singapore-headquartered private equity (PE) firm Quadria Capital has closed a revolving credit facility of up to $200 million. The facility will be used to finance its investments in healthcare, pharmaceutical, and diagnostics assets that improve access to healthcare across South Asia and Southeast Asia.

The loans drawn for the investments may be eligible to be classified as “social loans” in accordance with the Social Loan Principles published by the Loan Market Association and other regulatory organisations.

Quadria’s portfolio companies using these funds will report on pre-approved metrics to demonstrate the social impact of the firm’s investment.

The company used $77 million from the facility for investment in India’s Maxivision Eye Hospital in June this year.

“With this social loan, the first of its kind in Asia, we are bringing to the region financial innovations designed to channel capital into projects that create broad social impact.” said Abrar Mir, co-founder of Quadria Capital.

Quadria Capital, a healthcare-focused firm, recently made headlines when it roped in French development finance institution Proparco as a limited partner (LP) in its third fund that is targeting a corpus of $800 million. Other LPs that have already invested in the vehicle are International Finance Corporation (IFC) and Asian Development Bank.

In Southeast Asia, Quadria counts Hermina Hospitals, Lablink, and FV Hospital among its portfolio firms, while in India, it has invested in Medibuddy, Encube and Nobel Hygiene, among others.